Breast enlargement, also known as breast augmentation, involves placing an implant under the breast tissue to increase its size and shape. The implants can be inserted through incisions under the breast, in the armpit, or around the nipple. They can be positioned directly behind the breast, on top of the chest wall muscle, or behind the breast and chest wall muscle (sub-muscular). Breast implants are used for augmentation, reconstruction, and to improve the appearance of the breasts.
The field of breast implantation surgery has advanced substantially due to the increasing demand for cosmetic procedures. Many women who wish to enhance their appearance contribute considerably to the revenue of the breast implantation market. According to the FDA, women over the age of 18 are eligible for breast augmentation surgeries. In India alone, over 10,000 breast implantations are performed annually, and globally, more than 1.6 million augmentation procedures were carried out in 2023, making it one of the most popular cosmetic procedures worldwide.
The breast implant market is expanding due to the increasing prevalence of breast cancer. In severe cases, preventing this disease may require mastectomy surgery, which involves the removal of the entire organ. Reconstruction of the organ is a valuable option for treating such disease, involving reshaping the removed organ. In 2022, 2.3 million women were diagnosed with breast cancer, resulting in 670,000 deaths worldwide. It is estimated that in 2023, the number of new cases was 2,97,790 of invasive breast cancer will be diagnosed in U.S. women, along with 55,720 new cases of DCIS. As the number of reconstruction cases rises, there is an increasing demand for breast implantation over the forecast period.
Market players in the area are constantly developing better and more efficient solutions and improving the quality of available products through awareness campaigns about breast implants, product launches, collaborations, and mergers and acquisitions, all of which will support market growth. In June 2023, VSS Capital Partners, an investment firm focusing on healthcare, education, and business services, announced an investment in Olympus Cosmetic Group, a new platform offering comprehensive cosmetic surgery, dermatological treatments, and non-surgical cosmetic procedures. The introduction of advanced breast implants is expected to contribute to the market's growth.
North America Breast Implant Market
The breast implant market in North America is significant, with the United States poised to dominate. This dominance is driven by the high demand for cosmetic surgeries and procedures among women, with breast augmentation ranking among the leading five cosmetic surgical procedures in the United States in 2023. This trend underscores the potential for growth and investment opportunities in the region.The American Cancer Society reports that breast cancer accounts for about 30% of all new female cancer cases in the US annually. In 2023, it is estimated that there will be about 297,790 new cases of invasive breast cancer and 55,720 new cases of DCIS diagnosed in the US. Additionally, in 2022, 28,600 Canadian women were diagnosed with breast cancer, making up 25% of all new cancer cases in women in Canada.
In October 2022, the American College of Radiology initiated the CMIST trial in partnership with the Breast Cancer Research Foundation and GE Healthcare. The University of Texas MD Anderson Cancer Center and the World Health Organization (WHO) also formed an international collaboration to address the global impact of women's cancers.
Breast Implant Company Analysis:
Some major companies are present in the global breast implant industry. These are Abbvie Inc., Sientra Inc., Hans Biomed Co., Ltd, Establishment Labs SA, Guangzhou Wanhe Plastic Materials Co., Ideal Implant Inc., Laboratoires Arion, Polytech Health & Aesthetics GmbH, Mentor Worldwide LLC and Sebbin.Breast Implant Company News:
June 2023: Olympus Cosmetic Group, a recently established platform offering comprehensive cosmetic surgery, dermatological treatments, and non-surgical cosmetic procedures, recently received an investment from VSS Capital Partners.November 2023: Allergan Aesthetics, an AbbVie subsidiary, acknowledges the enormously personal choice that patients experience when selecting breast surgery. The new Natrelle® campaign, ""For Every BODY,"" celebrates patients and their stories using new imagery and visual assets. The campaign illustrates how any curve, shape, and BODY can have a personalized look with the Natrelle® breast implant collection.
October 2022: GC Anesthetics received CE approval for the micro-textured anatomical breast implant LUNA tx, allowed under the new European Medical Device Regulation (MDR).
June 2022: To meet breast reconstruction needs, Coll Plant announced the commencement of research in large animals for its 3D bio-printed regenerative breast implant program.
January 2022: The FDA has approved Mentor Worldwide LLC's MENTO MemoryGel BOOST breast implant for breast augmentation in women 22 and older.
Product- Market breakup in 2 viewpoints:
1. Silicone Implants2. Saline Implants
Shape - Market breakup in 2 viewpoints:
1. Round2. Anatomical
Application- Market breakup in 2 viewpoints:
1. Breast Cosmetic Surgery2. Breast Reconstruction Surgery
End User- Market breakup in 2 viewpoints:
1. Hospitals2. Cosmetology Clinics
Country - Market breakup of 17 Countries:
1. United States2. Brazil
3. Japan
4. Mexico
5. Turkey
6. Germany
7. Argentina
8. Italy
9. Colombia
10. India
11. Spain
12. Greece
13. Iran
14. Romania
15. United Kingdom
16. Thailand
17. Rest of the World
All the key players have been covered from 4 Viewpoints:
- Business Overview
- Product Portfolio
- Recent Development
- Revenue Analysis
Key Players Analysis:
1. Abbvie2. Sientra Inc.
3. Hans Biomed Co., Ltd
4. Establishment Labs SA
5. Guangzhou Wanhe Plastic Materials Co.
6. Ideal Implant Inc.
7. Laboratoires Arion
8. Polytech Health & Aesthetics GmbH
9. Mentor Worldwide LLCs
10. Sebbin
Table of Contents
Companies Mentioned
- Abbvie
- Sientra Inc.
- Hans Biomed Co., Ltd
- Establishment Labs SA
- Guangzhou Wanhe Plastic Materials Co.
- Ideal Implant Inc.
- Laboratoires Arion
- Polytech Health & Aesthetics GmbH
- Mentor Worldwide LLCs
- Sebbin
Methodology
In this report, for analyzing the future trends for the studied market during the forecast period, the publisher has incorporated rigorous statistical and econometric methods, further scrutinized by secondary, primary sources and by in-house experts, supported through their extensive data intelligence repository. The market is studied holistically from both demand and supply-side perspectives. This is carried out to analyze both end-user and producer behavior patterns, in the review period, which affects price, demand and consumption trends. As the study demands to analyze the long-term nature of the market, the identification of factors influencing the market is based on the fundamentality of the study market.
Through secondary and primary researches, which largely include interviews with industry participants, reliable statistics, and regional intelligence, are identified and are transformed to quantitative data through data extraction, and further applied for inferential purposes. The publisher's in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of their recommendations and advice.
Primary Research
The primary purpose of this phase is to extract qualitative information regarding the market from the key industry leaders. The primary research efforts include reaching out to participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions. The publisher also established professional corporate relations with various companies that allow us greater flexibility for reaching out to industry participants and commentators for interviews and discussions, fulfilling the following functions:
- Validates and improves the data quality and strengthens research proceeds
- Further develop the analyst team’s market understanding and expertise
- Supplies authentic information about market size, share, growth, and forecast
The researcher's primary research interview and discussion panels are typically composed of the most experienced industry members. These participants include, however, are not limited to:
- Chief executives and VPs of leading corporations specific to the industry
- Product and sales managers or country heads; channel partners and top level distributors; banking, investment, and valuation experts
- Key opinion leaders (KOLs)
Secondary Research
The publisher refers to a broad array of industry sources for their secondary research, which typically includes, however, is not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Patent and regulatory databases for understanding of technical & legal developments
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic new articles, webcasts, and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecasts
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 175 |
| Published | June 2024 |
| Forecast Period | 2023 - 2032 |
| Estimated Market Value ( USD | $ 2.32 Billion |
| Forecasted Market Value ( USD | $ 4.45 Billion |
| Compound Annual Growth Rate | 7.5% |
| Regions Covered | Global |
| No. of Companies Mentioned | 10 |
